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An audit of acute kidney injury - a prospective study of the epidemiology, management and outcome of 
patients with acute kidney injury, over a 12 month period at Groote Schuur Hospital, Cape Town, South 
Africa (a tertiary level teaching hospital). 
 
Introduction: 
Acute kidney injury results from a rapid decline in kidney function. There are many potential causes, some 
of which are preventable.  It carries the risks of mortality, progression to chronic kidney disease and 
worsening of pre-existing chronic kidney disease. There is a scarcity of data on the epidemiology of acute 
kidney injury in sub-Saharan Africa. The aims of this study were to describe the epidemiology of acute 
kidney injury at Groote Schuur hospital, and factors associated with mortality and renal recovery. 
 
Methods: 
This was a prospective observational study of patients with acute kidney injury, referred to Groote Schuur 
Hospital Renal Unit from the 8th of July 2012 to the 8th of July 2013. Ethics approval was granted by the 
University of Cape Town Human Research Ethics Committee. We excluded patients younger than 13 
years, kidney transplant patients, and those not fulfilling the consensus definition of acute kidney injury 
according to the Kidney Disease: Improving Global Outcomes (KDIGO) group. Data on patient 
demographics, medical history, clinical observations, investigations, and cause of acute kidney injury was 
collected from a clerking sheet designed for the study. Patients were followed up at, or after 3 months 
(90 days) for assessment of survival and renal recovery. The main outcomes were recovery of renal 
function and mortality at 3 months.  Data was entered into an Excel spreadsheet, and imported onto 
Stata 12.1 for analysis.  
 
Results: 
A total of 366 patients were included. The median age was 44 years (IQR 14-82). Of these 214 were male 
(58.5%). Referrals were from medical, surgical and obstetrics and gynaecology departments. The 
majority, 217 (59.3%) were medical referrals. Most, 265 (72.4%) had community acquired acute kidney 
injury.  The majority of the 101 patients with hospital acquired acute kidney injury, 72 (71.3%) had severe, 
stage 3 acute kidney injury. Hypertension was the commonest co-morbidity, present in 152 (41.5%) of the 
patients. There were 75 (20.6%) HIV positive patients.  Acute tubular necrosis was the most common 
cause of acute kidney injury, identified in 251 (68.6%) patients. Renal biopsies were carried out in 36 
(9.8%) patients. More than half, 202 (55.2%), of the patients were in the intensive care unit, while 204 
(55.7%) were dialysed. Fluid input was recorded in 140 patients (38.3%). Overall 3 month mortality was 
38.8% (142 patients). Of the 224 surviving patients, 119 (53.1%) had a follow up serum creatinine. Of 
these, 95 (80.5%) had full renal recovery, and 4 (3.4%) went on to end stage renal disease. On 
multivariate analysis, mechanical ventilation was strongly associated with mortality at 3 months (OR 2.46, 
p-value 0.019, 95% CI 1.41-4.03). Sepsis had a borderline significant association with 3 month mortality 
(OR 1.83, P-value 0.066, 95%CI 1.02 – 3.27), as did prolonged time to dialysis (OR 1.93, p-value 0.080, 




Acute kidney injury carries a high mortality risk, most significant in mechanically ventilated patients.  
Sepsis and, in those dialysed, late dialysis, may be associated with a high risk of mortality. Efforts to 




TABLE OF CONTENTS 
List of Tables ........................................................................................................................................... 5 
List of Appendices .................................................................................................................................. 6 
LITERATURE REVIEW ............................................................................................................................. 8 
Literature search strategy ......................................................................................................................... 8 
Definition and background of acute kidney injury .............................................................................. 8 
Epidemiology of acute kidney injury: ................................................................................................. 15 
Prevention and management of acute kidney injury: ...................................................................... 22 
Outcomes of acute kidney injury: ....................................................................................................... 29 
Identification of gaps and needs for further research ..................................................................... 31 
Aims and Objectives ................................................................................................................................ 33 
Methods ..................................................................................................................................................... 33 
Study Design ......................................................................................................................................... 33 
Setting .................................................................................................................................................... 33 
Eligibility Criteria ................................................................................................................................... 34 
Inclusion criteria ................................................................................................................................ 34 
Exclusion criteria .............................................................................................................................. 35 
Study Procedures ................................................................................................................................. 35 
Data Collection and management ..................................................................................................... 36 
Data collection instrument ............................................................................................................... 36 
Demographic and Epidemiological data ........................................................................................... 36 
Management data ................................................................................................................................ 37 
Dialysis data ...................................................................................................................................... 37 
Outcome data ....................................................................................................................................... 37 
Data management and validation ...................................................................................................... 38 
Statistical Considerations .................................................................................................................... 38 
Categorical data ................................................................................................................................... 38 
Continuous data ................................................................................................................................... 39 
Analysis of potential associations with mortality .............................................................................. 39 
Ethical Considerations ......................................................................................................................... 40 
RESULTS .................................................................................................................................................. 40 
5 
 
EPIDEMIOLOGY .................................................................................................................................. 40 
Demographics ....................................................................................................................................... 40 
Risk factors ............................................................................................................................................ 43 
Associations and causes of acute kidney injury .............................................................................. 44 
PREVENTION AND MANAGEMENT ............................................................................................... 49 
Timing of dialysis .............................................................................................................................. 51 
OUTCOMES ......................................................................................................................................... 52 
Mortality ............................................................................................................................................. 52 
Renal recovery .................................................................................................................................. 57 
DISCUSSION ............................................................................................................................................ 61 
Epidemiology......................................................................................................................................... 61 
Outcome ................................................................................................................................................ 67 
Study limitations ................................................................................................................................... 72 
REFERENCES ......................................................................................................................................... 76 
 
















List of Appendices 
Appendix 1 (Ethics approval) ………………………………………………………………………………………………………………95 
Appendix 2 (Data capture instrument and clerking sheet)………………………………………………………………96-97 
Appendix 3 (Renal biopsy results)……………………………………………………………………………………………………98-99 

















I would like to thank Professor Rayner for his guidance and support with this research 
project. I would also like to thank Kim Magnet for her assistance with aspects of data 
management.  
I am grateful to the doctors, clinical technologists, nursing staff, and administrative staff 
of the Groote Schuur Hospital Renal Unit for their role in patient management and 
record keeping during the study. I am grateful to Sister Chetty, from the Renal Unit who 
assisted with procuring data from patients receiving acute dialysis. 
I would like to convey a special thanks to Tawanda Chivese, of the Department of 
Health, University of Stellenbosch, South Africa, who assisted with the statistical 
analysis of the study. 
I dedicate this dissertation to my sister Siphiwe Refiloe Alice Dlamini, BA, LLB, LLM 










Literature search strategy 
 
Literature review involved searching for studies and reports on acute kidney injury using 
Medline, pub med, and Google Scholar. Key search words included acute kidney injury 
epidemiology, management and outcome. In addition, the terms acute kidney injury in 
developing countries, developed countries, Africa and South Africa were also used. 
Articles using the consensus definition of acute kidney injury were given preference. 
This is due to the fact that there was no clear biochemical definition of the condition 
prior to this, resulting in epidemiological data that was not reliable. However, landmark 
studies preceding the consensus definition of acute kidney injury were also reviewed. 
 
Definition and background of acute kidney injury 
 
Background 
Acute Kidney Injury is a syndrome that is characterized by an acute decline in kidney 
function (Bellomo, Kellum et al. 2012). There are numerous possible causes, ranging 
from volume responsive conditions to intrinsic renal parenchymal injury, urological 
obstruction and vascular occlusion (KDIGO 2012).  
The term acute kidney injury (AKI) was coined by the Acute Dialysis Quality Initiative 
(ADQI) group in 2004, together with the RIFLE criteria (Bellomo, Ronco et al. 2004). 
This was in an effort to address the lack of an agreed definition of the syndrome, which 
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was previously termed acute renal failure and which had over 35 definitions assigned to 
it (Kellum, Levin et al. 2002). The previous lack of a clear definition of acute kidney 
injury hampered efforts to investigate the epidemiology and full clinical and 
socioeconomic impact of this condition (Kellum, Levin et al. 2002).  
RIFLE classification 
The ADQI group defined and classified acute kidney injury according to the RIFLE 
criteria (Bellomo, Ronco et al. 2004). RIFLE is an acronym that describes increasing 
severity classes of renal impairment and outcome (Bellomo, Ronco et al. 2004). The 
severity classes of renal impairment are classified as Risk, Injury and Failure and are 
based on the most abnormal result amongst serum creatinine, glomerular filtration rate 
(GFR) and urine output. In addition, outcome criteria are described by the terms Loss 
and End stage renal disease, and are based on the duration of the kidney injury. In this 
way, RIFLE encompasses the full spectrum of acute kidney injury, from impairment of 
renal function to development of chronic kidney disease (KDIGO 2012).  
According to the RIFLE criteria, acute kidney injury can be diagnosed in the presence of 
a fall in GFR of >25% or an increase in serum creatinine of 1.5 times from baseline over 
a 1-7 day period. It can also be diagnosed by a fall in urine output of <0.5ml/kg/hour in 6 
hours (Bellomo, Ronco et al. 2004). This diagnostic criterion incorporates the Risk 
severity class. Injury is defined as either a 50% fall in GFR, a doubling of serum 
creatinine or a fall in urine output of <0.5ml/kg/hour for 12 hours. Failure is determined 
by changes in the level of serum creatinine whether in the form of an increase in serum 
creatinine of >75% from baseline, an increase of more than three times from baseline, 
or a level greater than 354µmol/l provided there was an increase of >44.4µmol/l from 
10 
 
baseline. In addition, Failure is diagnosed if a patient has a fall in urine output of 
<0.3ml/kg/hr for 24 hours, or anuria for 12 hours.  Loss is described as irreversible or 
persistent acute kidney injury for more than 4 weeks, and End stage renal disease if this 
persists for more than 3 months (Bellomo, Ronco et al. 2004). 
AKIN classification 
In 2007 the Acute Kidney Injury Network (AKIN) group modified the RIFLE classification 
of acute kidney injury by adding the rise in serum creatinine of 26.4µmol/l within 48 
hours, because this had been shown to carry a mortality risk in various studies. In 
addition acute kidney injury could be diagnosed if there was a fall in urine output of 
<0.5ml/kg/hour in > 6 hours, as defined by the RIFLE criteria (Mehta, Kellum et al. 
2007).  
 
The AKIN definition specified that patients first be fully resuscitated if determined to be 
volume responsive and that urinary tract obstruction be excluded. In addition, a new 
severity staging system was added. Stage 1 incorporated the serum creatinine increase 
of ≥ 26.4µmol/l from baseline, or a serum creatinine increase of a multiple of 1.5-2 from 
baseline, as well as the urine output requirements for the definition of acute kidney 
injury. Stage 2 combined the Injury and Failure criteria of RIFLE and stage 3 was similar 
to the Failure stage of the RIFLE criteria, but with the addition of an increase in serum 
creatinine of 26.4µmol/l above 354µmol, to incorporate the rise associated with 




The ability of both the RIFLE and AKIN criteria to predict mortality and severity of 
patient illness has been validated by numerous studies. However, studies have also 
shown that reliance on only one of these criteria to the exclusion of the other may miss 
some cases of acute kidney injury (KDIGO 2012). The Kidney Disease: Improving 
Global Outcomes (KDIGO) group has therefore combined both the AKIN and ADQI 
definitions in an attempt to provide a unified consensus definition of acute kidney injury 
(KDIGO 2012). This unified definition is also intended to enable uniformity for public 
health, clinical practice and research purposes (Lopes, Jorge 2013).  
The KDIGO definition incorporates the AKIN requirement of an increase in serum 
creatinine of ≥ 26.5µmol/l within 48 hours (The AKIN group had specified 26.4µmol/l 
which is the equivalent of 0.3mg/dl as opposed to the slightly different 26.5µmol/l that is 
used in the KDIGO classification). The KDIGO definition also incorporates the ADQI 
RIFLE criteria in the requirement for an increase in serum creatinine by a multiple of 1.5 
from baseline, over 7 days. Additionally, a decrease in urine output by < 0.5ml/kg/hour 
for > 6 hours also fulfils the requirements for the diagnosis of acute kidney injury 
(KDIGO 2012). 
The KDIGO group stages acute kidney injury for severity according to the AKIN criteria, 
using the more severe criterion between urine output and serum creatinine deterioration 
(Lopes, Jorge 2013, KDIGO 2012). According to this staging system, patients in whom 






Significance of acute kidney injury 
Acute kidney injury can lead to the development of chronic kidney disease. In patients 
with pre-existing chronic kidney disease, it accelerates progression to end stage renal 
disease and carries a mortality risk (Chertow, Burdick et al. 2005, Go, Chertow et al. 
2004, Lafrance, Miller 2010).  
 
In clinical practice there may be opportunities to identify patients at risk of developing 
acute kidney injury and to institute preventive measures (KDIGO 2012). Such measures 
may include pre-hydration before administering intravascular iodine based radio-
contrast agents to reduce the risk of contrast induced acute kidney injury (Anathhanam, 
Lewington 2013, Abelha, Botelho et al. 2009, KDIGO 2012). The early recognition of the 
underlying cause of acute kidney injury provides the opportunity to reverse or halt 
progression, such as the relief of urological obstruction or administration of 
immunosuppressive therapy for crescentic glomerulonephritis (KDIGO 2012).  
 
Problematic areas  
Serum creatinine 
Although the consensus definition of acute kidney injury is an important advancement, it 
is based on imperfect biomarkers for acute kidney injury (KDIGO 2012, Waikar, Liu et 
al. 2008). Serum creatinine levels can be increased by drugs such as trimethoprim 
without a decrease in GFR, by inhibition of renal tubular secretion of creatinine 
(Berglund, Killander et al. 1975, Andreev, Koopman et al. 1999). Serum creatinine 
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levels are also influenced by a patient’s muscle mass, because creatinine is the product 
of muscle metabolism (Lopes, Jorge 2013, Andreev, Koopman et al. 1999). Another 
drawback with serum creatinine as a biomarker for acute kidney injury is that its 
increase lags behind the fall in glomerular filtration rate, which can delay diagnosis, 
resulting in late initiation of treatment (Bonventre 2007).  
 
Urine output 
Although a fall in urine output may be a physiological response to hypovoalemia, its use 
as a marker of acute kidney injury remains important (Macedo, Malhotra et al. 2011, 
Kellum 2008). In a study by Macedo et al to assess the efficacy of urine output criteria in 
detecting acute kidney injury in intensive care unit (ICU) patients, additional episodes 
were diagnosed using urine output, as opposed to using serum creatinine alone 
(Macedo, Malhotra et al. 2011). However, the use of urine output as a marker of acute 
kidney injury also has potential drawbacks, for example, acute kidney injury may be 
non-oliguric if due to conditions such as aminoglycoside toxicity (KDIGO 2012).  
 
In response to the problems with the use of urine and serum creatinine in defining and 
detecting acute kidney injury, studies have looked at the use of novel urine and serum 
injury or damage biomarkers, the increase in which precedes changes in serum 
creatinine and urine output (Vanmassenhove, Vanholder et al. 2013). These include 
neutrophil gelatinase associated lipocalcin (NGAL), interleukin 18 (IL-18), kidney injury 
molecule 1 (KIM1), and liver-type fatty acid binding protein (L-FABP) (Siew, Ware et al. 
2011, McCullough, Shaw et al. 2013). The proposed benefit of these biomarkers is the 
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potential for early detection of acute kidney injury, thus enabling prompt action to 
reverse or prevent further decline in renal function (Vaidya, Ferguson et al. 2008).  
However, the use of the novel biomarkers is not without its limitations. An example of 
one such limitation was seen in a study which found that variations in NGAL levels have 
better predictive ability for acute kidney injury in paediatric cases rather than in adult 
cases (Haase, Bellomo et al. 2009).   
Levels of NGAL may also be affected by systemic and urinary tract infections, while 
levels of IL-18 may remain unchanged in pre-renal acute kidney injury, thus limiting their 
diagnostic utility (Parikh, Devarajan 2008). NGAL has also been found to have varying 
sensitivities and specificities depending on the stage of acute kidney injury. If a patient 
has mild acute kidney injury, NGAL is less useful as a diagnostic biomarker. However, 
as the severity of acute kidney injury increases, NGAL levels rise, making it a more 
reliable biomarker at this stage (Waikar, Betensky et al. 2012, Haase, Bellomo et al. 
2009). A further study in adult cardiac surgery patients found NGAL to have better 
predictive ability for acute kidney injury among patients with normal pre-operative 
baseline serum creatinine, compared to those who started off with an abnormal baseline 
(McIlroy, Wagener et al. 2010). Ultimately, the biggest drawback to the use of these 
novel biomarkers in clinical practice at the moment is their prohibitive cost (KDIGO 




Epidemiology of acute kidney injury: 
Early studies of acute kidney injury provided important epidemiological data that 
identified risk factors such as patient age, co-morbidities, intensive care unit (ICU) 
acquired acute kidney injury, the use of renal replacement therapy (haemodialysis), 
major surgery and the use of intravascular iodine based radio-contrast. (Shusterman, 
Strom et al. 1987, Liano, Pascual 1996, Nash, Hafeez et al. 2002). These early studies 
also showed that a small rise in serum creatinine was associated with mortality. 
However, while these studies were helpful in identifying patients at risk, there was often 
a wide variation in reported epidemiological data in similar regions, contributed to by the 
varied definitions of acute kidney injury that were employed. This affected the ability to 
appreciate the full impact of acute kidney injury. 
The consensus definition of acute kidney injury has provided a standardized tool for 
researching acute kidney injury and has made it possible to provide more reliable data 
on incidence and outcome (KDIGO 2012). This can help identify a true pattern of acute 
kidney injury in a geographical region which can aid with the implementation of 
preventive strategies, such as the allocation of medical and human resources (Cerda, 
Lameire et al. 2008, Lameire, Bagga et al. 2013) .  
Incidence and mortality 
Recent reports from developed countries such as the United States of America and 
Australia suggest that the incidence of acute kidney injury is rising, whilst the overall 
mortality rate is falling (Hsu, McCulloch et al. 2007, Waikar, Liu et al. 2008, Bagshaw, 
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George et al. 2007). In a retrospective analysis of ICU patients with acute kidney injury 
over a ten year period, Bagshaw et al found that although mortality rates were still high, 
the overall trend showed a decline over this period (Bagshaw, George et al. 2007). It is 
difficult to extrapolate these findings to Africa, as there is a paucity of epidemiological 
studies from the region (Naicker, Aboud et al. 2008). 
In addition, a review of current data reveals that the incidence of acute kidney injury can 
also vary depending on the population studied and the definition used for determining 
acute kidney injury. An example of variations in population studies is seen in incidence 
reports that range from 5000 cases per million per year in patients that do not require 
dialysis, to a lower rate of 295 cases per million per year for patients requiring dialysis 
(Bellomo, Kellum et al. 2012).  
Regional differences 
Studies suggest that there are differences in the epidemiology of acute kidney injury, 
depending on whether a region is classified as developed or developing (Cerdá, Bagga 
et al. 2008). These differences may be with respect to patient age, risk factors, cause 
and whether acute kidney injury is acquired in the community or in the hospital. 
Data from developed countries shows acute kidney injury to be most common in older 
patients. These patients typically have multiple co-morbidities (such as heart failure) 
and are managed in an ICU setting (Cerda, Lameire et al. 2008). Hospital acquired 
acute kidney injury is therefore more common in this context (Cerdá, Bagga et al. 2008). 
In developing countries, the epidemiology of acute kidney injury differs depending on 
whether one is in an urban or non-urban setting. In non-urban areas, acute kidney injury 
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affects younger patients. Patients tend to present with a single cause of acute kidney 
injury, including communicable diseases (such as malaria and infective gastroenteritis), 
obstetric causes (such as septic abortions and pre-eclampsia) and nephrotoxins 
(Naicker, Aboud et al. 2008, Okunola, Ayodele et al. 2012, Kaballo, Khogali et al. 2007, 
Cerdá, Bagga et al. 2008). Community acquired acute kidney injury is common in this 
context (Cerdá, Bagga et al. 2008). In contrast, the epidemiology of acute kidney injury 
in urbanized areas of developing countries is similar to that found in developed 
countries in that it is likely to present itself in older patients with co-morbidities and to be 
classified as hospital acquired (Lombardi, Yu et al. 2008).  
Causes  
Acute kidney injury can arise from pre-renal causes such as diarrhoeal illnesses, 
intrinsic renal causes (such as acute tubular necrosis, acute interstitial nephritis and 
glomerulonephritis), obstruction, and vascular causes. The detection of the underlying 
cause of acute kidney injury is important as some causes require prompt specific 
therapy, such as the relief of urological obstruction (KDIGO 2012). Acute kidney injury 
can also be precipitated by the prevailing risk factors present in different communities 
(Okusa, Chertow et al. 2009). For instance, patients from tropical areas may present 
with infectious diseases such as malaria and risks associated with envenomation by 
poisonous snakes (Cerda, Lameire et al. 2008, Cerdá, Bagga et al. 2008).  
 
Literature also points towards some unique epidemiological features due to infection 
with the human immunodeficiency virus (HIV), which is an important co-morbidity in 
many South Africans (Fabian, Naicker 2009, Wyatt, Arons et al. 2006, Arendse, 
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Okpechi et al. 2011, Lopes, Melo et al. 2011, Shisana, Rehle et al. 2009). Mortality 
rates were reported to be around six times higher among hospitalized HIV positive 
patients in the pre-highly active anti-retroviral therapy (HAART) era (Wyatt, Arons et al. 
2006, Naicker, Aboud et al. 2008). Since the widespread use of HAART, the trend in 
outcome of HIV positive patients with acute kidney injury has largely been similar to that 
of HIV negative patients (Nel, Moosa et al. 2012). In Cape Town, Arendse et al 
demonstrated a better outcome for HIV positive patients with CD4 counts greater than 
200, compared to those with lower CD4 levels (Arendse, Okpechi et al. 2011).  
 
Pathological causes of acute kidney injury 
Acute tubular necrosis is the most common cause of acute kidney injury (Waikar, Liu et 
al. 2008). The term itself is problematic as it is derived from studies of animal models 
where cortical necrosis arose from severe hypo-perfusion (Bellomo, Kellum et al. 2012, 
Devarajan 2005, Dunnill 1974). This is not typically the case in humans, where the 
pathological findings tend to be milder and to be due to tubular cell apoptosis rather 
than necrosis (Devarajan 2005). In humans, cortical necrosis is only found in cases of 
significant renal hypo-perfusion such as severe post-partum haemorrhage (Dunnill 
1974).   
While the definitive diagnosis of acute tubular necrosis is based on histology, in clinical 
practice this tends to be according to the clinical setting, urine microscopy (such as the 
finding of muddy brown granular casts and tubular epithelial cells) and the course 
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(Esson, Schrier 2002).  Causes of acute tubular necrosis include sepsis, nephrotoxins, 
and hypo-perfusion (Dunnill 1974).  
Sepsis 
Sepsis is a common cause of acute tubular necrosis where tubular injury results from 
inflammatory cytokine mediated intra-renal vasoconstriction and tubular apoptosis 
(Zarjou, Agarwal 2011). A study conducted in the North of Scotland found sepsis to be a 
leading cause of acute kidney injury in that region in that it was found in 47% of the 
patients (Ali, Khan et al. 2007). 
Nephrotoxins 
Acute kidney injury induced by nephrotoxins often presents differently depending on the 
regional context (Naicker, Aboud et al. 2008). For instance studies from South Africa 
highlight the use of herbal remedies as an important cause of nephrotoxicity (Luyckx, 
Steenkamp et al. 2005). The types of remedies used vary from herbal treatment of 
infertility to medicinal use for acute or chronic illnesses. This can be difficult to detect as 
some patients may not volunteer information about the use of such remedies (Luyckx, 
Naicker 2008, Swanepoel, Blockman et al. 2008). However, their detection as a cause 
of acute kidney injury provides an opportunity to educate against their future use in 
patients who survive (Swanepoel, Blockman et al. 2008). Although acute tubular 
necrosis is a common histopathological finding from these nephrotoxins, other acute 
renal histopathological patterns include acute interstitial nephritis and glomerular injury 
(Luyckx, Naicker 2008). 
Other nephrotoxins are synthetic or ‘over the counter’ preparations, such as potassium 
dichromate. Potassium dichromate is a component of some laxatives used by sections 
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of the South African population who believe them to be a ‘detoxification ‘agent 
(Swanepoel, Blockman et al. 2008).  
Studies in developed countries have identified intravascular iodinated radio-contrast 
media as an important potential nephrotoxin, causing contrast induced nephropathy 
(Hoste, Doom et al. 2011, Nash, Hafeez et al. 2002, Waikar, Liu et al. 2008). There are 
three principal mechanisms involved in contrast induced nephropathy. The first 
mechanism is through direct renal tubular toxicity by the iodinated radio-contrast agent, 
which causes disruption of mitochondrial function, creation of free radicals, and 
induction of renal tubular apoptosis. The second mechanism is through the induction of 
vasoconstriction by the radio-contrast agent, which reduces blood flow through the 
relatively hypoxic renal medulla, causing ischaemia and tubular cell damage.  Thirdly as 
another consequence of ischaemia, there is resultant formation of reactive oxygen 
species in the medulla, and these reactive oxygen species react with nitrogen to form 
peroxynitrite, which is itself toxic to the renal tubules (Markota, Markota et al. 2013). 
In the large epidemiological study of hospital acquired acute kidney injury by Nash et al, 
that preceded the consensus definition of acute kidney injury, contrast induced 
nephropathy was the third leading cause of hospital acquired acute kidney injury, 
accounting for 11% of cases (Nash, Hafeez et al. 2002). Risks of developing contrast 
induced nephropathy are increased with the use of high volume doses and those with 
high osmolality (McCullough 2008). Other pharmacological agents with nephrotoxic 
potential include aminoglycosides and amphotericin B, which typically cause non-
oliguric acute kidney injury (KDIGO 2012).  
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Acute kidney injury in surgical and Obstetrics and gynaecology cases 
Amongst surgical patients, risk factors for acute kidney injury include advanced age, 
high risk surgery, the presence of co-morbidities, and intra-operative use of inotropes 
(Kheterpal, Tremper et al. 2007). Furthermore acute kidney injury may result from 
abdominal compartment syndrome following abdominal surgery (Raeburn, Moore et al. 
2001, Maerz, Kaplan 2008). The resultant rise in intra-thoracic pressure following 
surgery is one of the mechanisms by which acute kidney injury may arise (Maerz, 
Kaplan 2008). Increased intra-thoracic pressure reduces venous return, which in turn 
increases renal vein pressures. It also causes increased extrinsic retroperitoneal 
pressure resulting in reduced glomerular filtration (Maerz, Kaplan 2008).  
In major vascular surgery, acute kidney injury can result from athero-emboli if there was 
pre-existing atherosclerosis. Other causes include the duration of supra-renal aortic 
clamp time and the inflammatory response resulting from the surgical procedure 
(Welten, Chonchol et al. 2008).     
In cardiac surgery acute kidney injury can arise from renal hypo-perfusion and a fall in 
mean arterial pressure, leading to ischaemia (Karkouti, Wijeysundera et al. 2009). Other 
postulated causes include cytokine mediated effects induced firstly by the surgical 
procedure and secondly by the contact of blood with the cardiopulmonary bypass 
circuit. A further possible reason is nephrotoxicity caused by the release of free 
haemoglobin and iron into the circulation during the procedure (Karkouti, Wijeysundera 
et al. 2009).  
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Amongst obstetrics and gynaecology patients, causes of acute kidney injury reported in 
developing countries include acute tubular necrosis as a result of peri-partum 
haemorrhage (Okunola, Ayodele et al. 2012). For instance, in parts of Nigeria acute 
kidney injury in obstetrics and gynaecology patients has been linked to poor antenatal 
care, highlighting the important potential role of prevention (Okunola, Ayodele et al. 
2012, Naicker, Aboud et al. 2008). Pre-eclampsia is another important cause of acute 
kidney injury, and is mainly caused by soluble vascular endothelial growth factor that 
causes glomerular endothelial swelling and loss of fenestrae (Stillman, Karumanchi 
2007, Naicker, Aboud et al. 2008) .  
 
Prevention and management of acute kidney injury: 
As there is currently no specific treatment for acute tubular necrosis, which is the most 
common cause of acute kidney, prevention remains essential in its management 
(Chawla, Amdur et al. 2011). For other causes of acute kidney injury such as crescentic 
glomerulonephritis, or urological obstruction, a basic approach including urinalysis and 
kidney ureter ultrasonography can identify patients that can benefit from directed 
therapy such as immunosuppression and relief of the obstruction respectively (KDIGO 
2012). 
Preventive strategies 
There are many steps that clinicians can take in the management of patients to prevent, 
reverse or halt acute kidney injury (KDIGO 2012, Venkataraman 2008). For critically ill 
patients, the principles of early goal directed therapy can be employed (Rivers, Nguyen 
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et al. 2001, KDIGO 2012). Rivers et al conducted a single centre randomized controlled 
study comparing early goal directed therapy to standard therapy (Rivers, Nguyen et al. 
2001). Early goal directed therapy involved assigning patients with severe sepsis to 
prompt management, to achieve pre-determined clinical parameters within six hours of 
their admission to ICU. Although acute kidney injury  was not an outcome measure in 
this study, the patients with early goal directed therapy had better urine output and 
lower in-hospital mortality (Rivers, Nguyen et al. 2001).  
A preventive strategy that is in use in hospitals in the United Kingdom involves the use 
of an’ early warning score’, a scoring system that is incorporated into the patient’s 
observation charts. This system has been shown to correlate to mortality and to aid 
early detection of deteriorating patients, thus enabling prompt intervention (Goldhill, 
McNarry et al. 2005). 
Patients requiring intravascular iodine based radio-contrast in diagnostic procedures 
have been shown to have reduced risks of contrast induced acute kidney injury if 
intravascular pre-hydration is instituted (Venkataraman 2008). One study showed 
additional benefit from both intravenous pre-hydration and alkalinisation of urine to a pH 
of greater than 6, with oral citrate. This effect was attributed to a resultant reduction in 
the formation of nephrotoxic free-radicals (Markota, Markota et al. 2013).  
Fluid therapy is vital for patients with volume responsive acute kidney injury (KDIGO 
2012). However, caution should be taken to avoid fluid overload as studies have clearly 
linked fluid overload to an increased risk of mortality (Vincent, Sakr et al. 2006, Payen, 
de Pont et al. 2008, Teixeira, Garzotto et al. 2013).  
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Many studies have looked at the effects of specific types of colloids and crystalloids on 
renal injury and patient mortality (KDIGO 2012). Fluid resuscitation using synthetic high 
molecular weight colloids has been linked to acute kidney injury, presumably due to 
tubular injury from osmotic nephrosis (Dickenmann, Oettl et al. 2008). However, the use 
of albumin for fluid resuscitation has not been linked to adverse outcomes (Finfer, 
Norton et al. 2004). On the other hand, the use of normal saline for volume replacement 
has been shown to cause hyperchloraemic metabolic acidosis, which carries a mortality 
risk (Bellomo, Hegarty et al. 2012).  
Investigations  
Recommended investigations to elicit the cause of acute kidney injury include urinalysis 
(urine dipstick and urine microscopy) and kidney ureter bladder ultrasonography. In 
addition, some patients may require a renal biopsy (KDIGO 2012). Urine microscopy 
has been shown to be a good predictor of acute kidney injury severity, with recognized 
scoring systems (Perazella, Coca et al. 2010). Findings such as red cell casts, together 
with the clinical picture, can aid towards making a diagnosis of crescentic 
glomerulonephritis, for which prompt immunosuppression is required (KDIGO 2012). 
Treatment 
Many patients go on to require renal replacement therapy to treat the complications 
(such as refractory hyperkalaemia) that cannot be managed by medical therapy alone. 
(KDIGO 2012).  
The forms of dialysis employed in the treatment of acute kidney injury include 
intermittent modalities such as intermittent haemodialysis and sustained low efficiency 
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haemodialysis and continuous replacement therapy, such as continuous veno-venous 
haemodialysis and peritoneal dialysis (KDIGO 2012). Studies have found no difference 
in patient outcomes between the use of intermittent haemodialysis and haemodialysis 
involving continuous renal replacement therapy (Bagshaw, Brophy et al. 2008).  
In clinical practice however, patients with haemodynamic instability, head injuries and 
raised intracranial pressure are managed with continuous renal replacement therapy, 
and those without these risk factors are treated with intermittent haemodialysis (KDIGO 
2012).  
Although the use of peritoneal dialysis for adults is less common in developed countries, 
this modality is commonly used in developing countries (Gabriel, Caramori et al. 2009). 
It has been demonstrated that this form of therapy can be administered in resource 
limited settings, such as in Moshi, Tanzania, with encouraging results (Kajiru Kilonzo, 
Croome 2013).  
 
Dialysis dose 
 The Randomized Evaluation of Normal versus Augmented Level replacement therapy 
(RENAL) trial and the Veterans Affairs/National Institute of Health Acute Renal Failure  
Trial Network (ATN) trial looked at the intensity of continuous renal replacement therapy 
in critically ill patients (RENAL Replacement Therapy Study Investigators, Bellomo et al. 
2009, VA/NIH Acute Renal Failure Trial Network, Palevsky et al. 2008). The RENAL trial 
found that no additional benefit was derived from doses higher than an effluent of 
40ml/kg/hour versus 25ml/kg/hour, and the ATN trial found no added benefit from doses 
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of 35ml/kg/hour versus 20ml/kg/hour. Based on the above trial data, the recommended 
view is that the optimal dose be assigned at 20-30ml/kg/hour of dialysis effluent (KDIGO 
2012). 
 
Timing of dialysis 
The optimal timing of dialysis initiation is an issue that requires further qualification 
(Yong, Dogra et al. 2011). From the literature review, this appears to be due to the fact 
that studies have looked at timing based on different categories, namely, blood urea 
nitrogen (BUN) levels, serum creatinine levels and the use chronological time, with 
conflicting results. However, the argument can be made that early initiation of dialysis 
translates to better patient outcomes irrespective of the category used (Palevsky 2008).  
BUN and chronological time 
The Project to improve Care in Acute Renal Disease (PICARD) study found that 
initiating dialysis at higher BUN levels was associated with higher mortality rates (Liu, 
Himmelfarb et al. 2006), supporting the initiation of dialysis at lower BUN levels. In 
contrast, the Beginning and Ending Supportive Therapy for the Kidney (BEST KIDNEY) 
study found that it was the duration of time before dialysis initiation that correlated to a 
higher mortality, rather than high BUN levels (Bagshaw, Uchino et al. 2007). This 





The BEST KIDNEY study also found that a higher serum creatinine level at the initiation 
of dialysis was associated with lower mortality rates (Bagshaw, Uchino et al. 2007).  
This finding was seemingly paradoxical because one would expect a more severe 
kidney injury (and higher mortality rate), where serum creatinine levels are higher. 
However, this apparent paradox is explained by a study that looked at the association 
between survival and serum creatinine level at the start of dialysis. This study found that 
higher serum creatinine levels were associated with better survival (Cerda, Cerda et al. 
2007). Furthermore, this finding was not affected by the nutritional status of patients 
(better nourished patients would be expected to have higher serum creatinine levels). 
Cerda, Cerda et al hypothesized that this protective effect was due to underlying chronic 
kidney disease, meaning that a lesser degree of acute kidney injury was required to 
necessitate dialysis in such patients (Cerda, Cerda et al. 2007). They also raised the 
possibility that a lower serum creatinine level may be due to fluid overload, which has 
been associated with increased mortality (Cerda, Cerda et al. 2007).  
The failure of serum creatinine and BUN levels to reliably guide optimal timing of 
dialysis in the BEST KIDNEY study illustrated the potential shortcomings of their use as 
biomarkers of acute kidney injury (Bagshaw, Uchino et al. 2007).  
 
Supportive treatment  
Nutrition 
It is recommended that patients with acute kidney injury receive a calorie intake of 20-
30 kilocalories per kilogram per day, preferably by the enteral route (KDIGO 2012). The 
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importance of adequate nutrition is supported by a study by Scheikenstel et al in 
critically ill patients with acute kidney injury that showed an association between a 
negative nitrogen balance and in-hospital mortality (Scheinkestel, Kar et al. 2003) . In 
addition, the use of continuous renal replacement therapy itself has been shown to 
cause losses of amino acids, potentially contributing to a negative nitrogen balance 
(Hynote, McCamish et al. 1995) .  
Glucose control 
Glycaemic control has been extensively studied in ICU-managed medical and surgical 
patients. Surgical patients have been shown to benefit from the use of intensive insulin 
therapy to achieve tight glucose control in that this led to lower mortality rates (Van Den 
Berghe, Wouters et al. 2001). In contrast, intensive insulin therapy in medical patients 
has been associated with significant hypoglycaemia and increased mortality rates 
(Griesdale, de Souza et al. 2009).  
Although hyperglycaemia also carries a mortality risk and ought to be treated with 
insulin therapy if required, it is now accepted that such treatment should not entail tight  
glucose control as this may be harmful in non-surgical ICU patients (KDIGO 2012, 







Outcomes of acute kidney injury: 
Mortality  
As previously discussed acute kidney injury with a rise in serum creatinine as small as 
26.4µmol/l is linked to mortality (Chertow, Burdick et al. 2005, Lassnigg, Schmidlin et al. 
2004). The increase in mortality correlates with the increase in severity of acute kidney 
injury (Thakar, Christianson et al. 2009, Chawla, Amdur et al. 2011). 
The majority of the data on mortality rates in acute kidney injury is based on findings 
from large studies undertaken prior to the consensus definition, with figures ranging 
from 15%-50% (Kellum 2008). In addition, mortality rates in patients requiring dialysis 
were placed as high as 50% to 60% (Hoste, Schurgers 2008).  However, a recent 
systematic review of cohort studies of acute kidney injury from 2004 to 2012, which 
used the KDIGO classification, reported a pooled mortality rate of 23.9% in adults 
(Susantitaphong, Cruz et al. 2013).  
Although data on in-hospital mortality is important, following patients up at 90 days (3 
months) allows detection of those who have not recovered renal function by this stage, 
and who, by definition, have progressed to chronic kidney disease (KDIGO 2012). 
These patients are important to identify because they can be offered follow up and 
management to slow progression to end stage renal disease such as blood pressure 
control, and treatment of metabolic acidosis (Kidney Disease: Improving Global 
Outcomes (KDIGO) CKD-MBD Work Group 2009).  Additionally, should they progress 
to end stage renal disease, their close follow up can enable timely and safe preparation 
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for renal replacement therapy, in the way of a pre-emptive kidney transplant if possible, 
arteriovenous fistula for haemodialysis or tenckhoff catheter insertion for peritoneal 
dialysis (Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group 
2009). 
The Finnish Acute Kidney (FINNAKI) study followed up patients who were admitted in 
Finnish ICUs over a 12 month period in 2012, and found an overall 90 day mortality rate 
of 39.2% (Nisula, Kaukonen et al. 2013). This study employed the KDIGO definition of 
acute kidney injury (Nisula, Kaukonen et al. 2013). 
 
Determinants of outcome 
Mortality  
Studies have identified elderly and paediatric patients as having worse outcomes 
following acute kidney injury (Cerda, Lameire et al. 2008, Lombardi, Yu et al. 2008). 
Additional contributors to poorer outcome in older patients in developing countries are 
multiple co-morbidities (Lombardi, Yu et al. 2008). The mortality of acute kidney injury 
patients with underlying chronic kidney disease has been found to be lower, presumably 
because smaller deteriorations in renal function are required in order to attain a severe 
stage of acute kidney injury in such patients (Waikar, Liu et al. 2008). 
Renal recovery 
The definition of renal recovery in many studies of acute kidney injury has previously 
been dialysis independence at the time of hospital discharge (Macedo, Bouchard et al. 
2008). The ADQI group defined renal recovery as complete in cases where a patient 
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returns to their baseline classification within the RIFLE criteria. Partial renal recovery 
was attributed to patients who have a persistent deterioration in classification but are 
not dialysis dependent. End stage renal disease was diagnosed if patients remained 
dialysis dependent after 3 months (Bagshaw, Laupland et al. 2005). Reports from the 
study by Ali et al, which was a population study, found that 92.5% of surviving patients 
had full renal recovery, 7% had partial renal recovery and 0.6% had no recovery (Ali, 
Khan et al. 2007).  
 
Identification of gaps and needs for further research 
This review of existing literature on acute kidney injury has led to an identification of 
areas requiring further research. A useful study would be one that looks at the effect of 
simple, protocol based clinical scoring systems in developing countries. These scoring 
systems can be used to alert clinicians to patients at risk of acute kidney injury, thus 
providing an opportunity for early intervention. 
Another area of research could be one that replicates and expands on the study by 
Markota et al. As previously discussed, this study was important in that it demonstrated 
a benefit in achieving a urine alkalinity of pH of >6, for protecting against contrast 
induced nephropathy. This level of urine alkalinity was hypothesized to protect against 
the formation of free-radicals in the renal medulla. Previous studies of the role of 
alkalinisation (using sodium bicarbonate) have shown mixed results. A possible 
explanation for this discrepancy may be that unlike in the study by Markota et al, the 
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urine alkalinity was not assessed and therefore ineffective doses of bicarbonate may 
have been administered. 
 Lastly, the literature review has demonstrated that further studies on the optimal timing 
of renal replacement therapy are still required. This is especially the case where 
patients may not fulfill the traditional indications for initiation of dialysis, but may have 














Aims and Objectives 
 To investigate the epidemiology of acute kidney injury at Groote Schuur 
Hospital. 
 To investigate the management of acute kidney injury at Groote Schuur 
Hospital.  
 To identify possible preventive measures in the development of acute 
kidney injury in the Groote Schuur Hospital setting. 
 To investigate the outcome of patients with acute kidney injury in terms of 
90 day mortality, progression to chronic kidney disease and level of 
recovery of renal function. 
 To determine if timing of dialysis affects patient outcome. 
Methods 
Study Design 
A prospective cohort study of patients referred to Groote Schuur Hospital Renal Unit with 
acute kidney injury from the 8th of July 2012 to the 8th of July 2013. 
 
Setting 
The study was carried out at the Renal Unit of Groote Schuur Hospital, Cape Town, South 







Patients with native (non-transplant) kidneys who were above the age of 13 and referred 
to the renal unit with acute kidney injury were eligible if they fulfilled the KDIGO definition 
of acute kidney injury. The study included patients referred from the medical, surgical and 
obstetrics and gynaecology disciplines. We included patients managed in the ICU and 
patients with all 3 stages of acute kidney injury. 
 
Acute kidney injury diagnosis 
Where baseline serum creatinine was not known, patients who went on to demonstrate 
an improvement in serum creatinine (independent of dialysis) were deemed to have 
undergone an episode of acute kidney injury. We did not employ the use of an estimated 
baseline serum creatinine based on the Modification of Diet in Renal Disease (MDRD) 
study equation, as has been done in other studies (This is further discussed under the 
section entitled ‘study limitations’ in this paper).  
 
Patients with no known pre-existing serum creatinine level were staged according to the 
level of recovery in serum creatinine. In addition, all patients in whom renal replacement 






The cohort excluded children under the age of 13 who would have been referred to the 
nearby Red Cross Children’s Hospital. Other patients excluded included those on renal 




Patient details were obtained from doctors rotating through the renal unit. Patients were 
then located and data collected retrospectively from the clerking sheet designed to 
incorporate information required as a basic standard for patients with acute kidney injury. 
This clerking sheet also served as a data capture sheet (Appendix 2). Further and missing 
data was retrospectively obtained from the electronic laboratory database and hospital 
record database. Patients were contacted at or after three months (ninety days) following 
the acute kidney injury episode, to present themselves for a repeat serum creatinine level.  
Electronic laboratory details were also sought for three month or post three month 
creatinine levels for patients who were not able to return for follow up. Patients who had 
abnormal serum creatinine levels were referred for follow up in the Renal Unit. 
 
Patients in whom acute kidney injury developed during their hospital admission were 
deemed to have hospital acquired acute kidney injury. Patients with abnormal results on 
admission, as well as those whose presenting conditions on admission are known to 
predispose to community acquired acute kidney injury (such as gastroenteritis), were 
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labeled as having community acquired acute kidney injury. This included patients referred 
from secondary and primary level institutions.  
Data Collection and management 
Data collection instrument 
Primary data was entered onto a data collection form designed to be used by clinicians 
when seeing patients. This clerking sheet collected data on patient demographics, clinical 
status, patient management, laboratory results and outcome measures. Confirmation of 
data on patient ethnicity was obtained from hospital records. Data was then recorded on 
an Excel spreadsheet. 
Demographic and Epidemiological data 
This included patient age, gender, and ethnicity. Information collected also included past 
medical history, habits, and reason for admission, as well as risk factors for acute kidney 
injury. Epidemiological data included information on patient illness severity. 
 
Not all patients had the required data to enable the use of the Acute Physiology and 
Chronic Health Evaluation (APACHE) scoring system. The decision was therefore made 
to utilize the acute kidney injury stage (assigning clinical severity to stage 3) as a 
surrogate marker of patient clinical severity. This marker has previously been shown to 
correlate with the clinical state and outcome of patients with acute kidney injury 
(Barrantes, Tian et al. 2008, Ostermann, Chang 2009). The data collected also included 
potential causes of acute kidney injury such as trauma, sepsis, toxins (herbal and 
synthetic), obstetric causes, intrinsic renal, pre-renal and obstructive causes. Data on 
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potential risk factors and associations with acute kidney injury, such as hypertension, 
diabetes mellitus, chronic kidney disease, heart disease, and substance abuse was also 
collected. 
Management data 
Management data included the department referring the patient (medicine, surgery or 
obstetrics and gynecology), whether the patient was managed in the ICU or not, whether 
the patient received dialysis or not, whether investigations included fluid balance, urine 
output, urine dipstick, urine microscopy, kidney ureter bladder ultra sound scan, or renal 
biopsy, and whether patients were mechanically ventilated or on inotropes. 
Dialysis data 
The investigators collected data on the dialysis modality employed. A number of patients 
inter-changed the dialysis modalities and were considered under the first dialysis mode 
used. Time to dialysis initiation from the diagnosis of acute kidney injury was measured 
for each patient in days. 
Outcome data 
The investigators considered two outcomes, namely mortality and recovery of renal 
function.  
 Mortality was measured at two intervals - at 30 days and at 90 days. This was a 
binary (alive/dead) outcome.  
 Recovery of renal function was measured using two criteria. These were 
independence from dialysis, and the return of serum creatinine levels to within 1.5 
times the patient’s baseline at three months follow-up. In patients with no known 
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baseline creatinine the investigators used the “normal” National Health Laboratory 
Service range of 41-90µmol/l. Our definition of renal recovery was based on that 
of the ADQI group, where full renal recovery is return to the baseline RIFLE 
classification (serum creatinine less than a multiple of 1.5 from baseline), partial 
recovery if patients persist at a more severe RIFLE class but are not dialysis 
dependent, and End stage renal disease if they are dialysis dependent after three 
months (Bagshaw, Laupland et al. 2005). Where the baseline serum creatinine 
level was unknown, patients whose renal function recovered to a level within the 
laboratory reference range were assessed as fully recovered.  
Data management and validation 
Data was retrospectively entered into an Excel spreadsheet from the clerking sheet. The 
data was entered onto the spreadsheet by the principal investigator and assistants. 
Attempts were made to find missing data from laboratory records and the patients’ 
hospital records. Outliers were double-checked with patient records. 
Statistical Considerations 
The data in the excel spreadsheet was cleaned and imported into Stata 12.1 for analysis 
(Stata Corporation, College Station, TX, USA). All statistical analyses were carried out 
using Stata 12.1. All statistical hypotheses were carried out at a 5% level of significance 
and 95% confidence intervals (CI) were reported.  
Categorical data 





The data was tested for normality using the Shapiro-Wilks test. For normally distributed 
data, means and standard deviations were described while medians and interquartile 
ranges (IQR) were described for non-normally distributed data. 
The investigators used the t-test and its variants to test associations between normally 
distributed variables and groups while the Mann-Whitney U test and its non-parametric 
variants was used to test associations in non-normally distributed data. 
Analysis of potential associations with mortality 
The investigators used Odds Ratios (OR), P-values and 95% confidence intervals to 
describe associations. Univariate relationships between potential determinants of 
mortality at 3 months were tested and reported. Epidemiological variables, co-morbidities 
and management variables were considered. 
 
Multivariate analysis of determinants of mortality at 3 months was carried out using 
forward stepwise logistic regression, with a 0.05 significance level for addition and a 0.15 
significance level for removal of variables. The investigators included variables with a P-
value of less than 0.20 from the univariate analysis. Demographic variables considered 
as confounders were age, gender and ethnicity. 
 
Further analysis included dialyzed patients only. The effect of the timing of dialysis was 
explored, with the time (days) to dialysis from acute kidney injury onset categorized into 
early (1 day), delayed (2 – 5days) and late (>5 days). This categorization of timing of 
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dialysis was based on that used in the BEST KIDNEY study (Bagshaw, Uchino et al. 
2007). Day 1 was the day of admission.  
 
Ethical Considerations 
Ethical approval was sought and granted by the University of Cape Town Human 
Research Ethics Committee. The data collection instrument was a clerking sheet 
designed for the study and subsequently used in standard practice. However, as the study 
did not involve further intervention in addition to standard patient management by the 









We included a total of 366 patients from the 8th of July 2012 to the 8th of July 2013 
(Table 1). Of these 214 (58.5%) were male. The ethnic distribution was comprised of 
183 (50%) Coloured patients, 146 (39.9%) Black, 35 (9.6%) White, and 2 (0.5%) were 
classified as Other (Table 1). 
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The median age was 44 (IQR 14 – 82). The 41-65 age category had 156 patients 
(42.6%), followed closely by the 19-40 category with 143 (39.1%) of the patients, while 
there were 57 patients (15.6%) aged 66 and older, and only 10 patients (2.7%) aged 18 
or younger (Table 1). 
The source of acute kidney injury was community acquired for 265 patients (72.4%), 
while 101 (27.6%) had hospital acquired acute kidney injury (Table 1). 
Medical referrals were made up of 217 patients (59.3%), followed by 124 (33.9%) 
surgical patients and 25 (6.8%) obstetrics and gynaecology patients (Table 1). 
Amongst the 124 patients referred from the surgical department, 66 (18.0%) had non 
cardiovascular surgery, and 30 (8.2%) had cardiovascular surgery. Of the 25 referred 
from the obstetrics and gynecology departments, 4 (1.1%), had surgery (Table 1). 
The number of patients with stage 3 acute kidney injury disease was 307 (83.9%) 
(Table 1). 
Of the 101 patients with hospital acquired acute kidney injury, 72 (71.3%) had stage 3 
acute kidney injury (Table 9).  
Table 1 – Demographic data, N = 366 
 
 Variable          Total          (%)                                   Mean         Range         SD             Median              IQR        
Age  
Age (years)                                                                 45.6            13-91         16.6            44                     14-82  
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≤ 18 years           10           2.7%     
19-40 years        143         39.1%     
41-65 years        156         42.6%  
≥ 66years             57         15.6% 
Gender and ethnicity 
Male                   214           58.5% 
Female               152           41.5% 
Coloured             183           50.0% 
Black                   146           39.9%  
White                    35             9.6% 
Other                      2             0.5% 
Referring discipline  
Medical                 217          59.3% 
Surgical                124          33.9% 
Obs/Gyn                25            6.8%     
Surgical procedure 
*CV surgery           30             8.2% 
*Obs/gyn surgery     4              1.1%  
*Gen/orth surgery   66           18.0% 
43 
 
*AKI source and stage 
Community AKI       265           72.4% 
Hospital AKI            101           27.6% 
AKI stage 1              27             7.4% 
AKI stage 2              32             8.7% 
AKI stage 3        307            83.9% 
*(AKI – acute kidney injury, CV – cardiovascular, Gen/Orth – general or orthopaedics, Obs/Gyn – 





Hypertension was the most common co-morbidity and was present in 152 (41.9%) of 
the patients. Other co-morbidities included diabetes mellitus in 65 (17.8%), heart 
disease in 58 (16.1%), trauma in 41 (11.2%), mycobacterium tuberculosis (TB) in 20 
(5.5%), pregnancy in 17 (4.5%) and cancer in 16 (4.4%) including 3 (0.82%) with 
multiple myeloma. The number of patients with HIV was 75 (20.6%) (Table 2).  Of the 
HIV positive patients, 46 (61.3%), were in the 19-40 years age range (Table 2). Overall 
prior chronic kidney disease was identified in 37 (10.1%) patients, including 10 (2.7%) 
patients with HIV associated nephropathy (Table 2). 
Table 2 – Acute kidney injury risk factors and co-morbidities 
44 
 
Variable                                                                                         Total (%)                                        
Hypertension                                                                                  152 (41.5)                                           
HIV                                                                                                  75 (20.6)      
HIV and age category in years,  N (%)                                                                                 
- 0-18                                                                                       0 
- 19-40                                                                                 46 (61.3) 
- 41-65                                                                                 27 (36.0) 
- ≥ 66                                                                                    2 (2.7) 
Diabetes mellitus                                                                            65 (17.8)                                                   
Heart disease                                                                                 58 (16.1)                                                  
Chronic kidney disease                                                                  37 (10.1)         
- including biopsy proven HIVAN                                         - 10 (2.7) 
Active TB                                                                                        20 (5.5)                                                                                                                                       
Pregnancy                                                                                      17 (4.6)                                                  
Cancer                                                                                            16 (4.4)                                                  
Cerebrovascular disease                                                                 8 (2.0)                                                     
 
Associations and causes of acute kidney injury 
Sepsis was present in 222 (60.7%) patients. It was either the sole cause or one of the 
causes of acute kidney injury in patients who had more than one potential cause (Table 
45 
 
3).  Of the 101 patients with hospital acquired acute kidney injury 63 (62.4%) had sepsis 
(Table 9).  
 
A biopsy proven diagnosis of acute kidney injury was obtained in 36 (9.8%) of the 
patients (Table 4 and Appendix 3).  
Acute tubular necrosis was the most common underlying cause of acute kidney injury, 
present in 272 (72.1%) of the patients (Table 4). Pre-renal causes of acute tubular 
necrosis included gastroenteritis, vomiting and dehydration in 47 (12.8%) patients, and 
4 (1.1%) from obstetric haemorrhage (Table 3). A total of 137 (37.4%) patients had 
acute tubular necrosis secondary to exogenous nephrotoxins. These included 7 (1.9%) 
due to herbal medication, 23 (6.3%) due to tenofovir, 10 (2.7%) due to aminoglycosides, 
and 50 (13.7%) due to intravascular iodine based radiocontrast agents (Table 4). 
Additional intrinsic renal causes of acute kidney injury included 20 (5.5%) due to 
glomerulonephritis (including one clinical diagnosis), 19 (5.2%) due to acute interstitial 
nephritis, 19 (5.2%) due to pyelonephritis, and 7 (1.9%) due to malignant hypertension. 
A thrombotic cause was identified in 1 (0.27%) patient with renal infarcts. Acute kidney 
injury due to obstruction was identified in 17 (4.6%) patients (Table 4 and Appendix 3). 
Among the Obstetrics and gynaecology patients compared to the total study 
population,14 (3.8%) had pre-eclampsia and 1(0.27%) presented following a septic 
abortion (Table 3).  
A total of 96 (26.2%) patients developed acute kidney injury in relation to a surgical 
procedure (Table 1). In addition, 41(11.2%) had trauma as a cause, including 5 (1.4%) 
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with crush syndrome secondary to mob violence (Tables 3 and 4).  A total of 16 (4.4%) 
patients presented following acute pancreatitis, and in 4 (1.1%) of these the cause was 
alchohol (Table 3). 
A total of 305 (83.3%) patients had a single presumed or known histological cause of 
acute kidney injury, but 61 (16.7%) had more than one known or presumed histological 






Table 3 – Precipitants/causes of acute kidney injury  
Variable, N (%)                                                                                                 Total (% of the total of 366 patients 
in the study unless otherwise 
specified) 
Sepsis (as either the sole cause or one of the causes)  
- pneumonia  
- pyelonephritis/urosepsis       
- sepsis post trauma 
- acute gastrointestinal tract pathology*  
- soft tissue 
222 (60.7%) 
- 42/222 (18.9%) 
- 27/222 (12.2%) 
- 24/222 (10.8%) 
- 24/222 (10.8%) 
- 6/222 (2.7%) 
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- bacterial gastroenteritis                    
- meningitis           
- septic arthritis 
- septic abortion (also included later in this table)   
- other                                       
Toxins                                                                                                       
- IV contrast                                                                               
- Tenofovir                                                  
- Aminoglycosides                                                                                
- Herbal toxins                                              
- Other exogenous toxins                                                   
Gastroenteritis/vomiting/dehydration                    
Cardiovascular surgery related      
Non cardiovascular, non obstetric surgery related                                   
Trauma                                                       
Pancreatitis                                                  
Abdominal compartment syndrome                                  
Pre-eclampsia         
Obstetric haemorrhage           
Septic abortion                             
Obstruction   
- 4/222 (1.8%) 
- 2/222 (0.9%) 
- 2/222 (0.9%) 
- 1/222 (0.5%) 
- 90/222 (40.5%) 
137 (37.4%) 
- 50 (13.7%) 
- 23 (6.3%) 
- 10 (2.7%) 
- 7 (1.9%) 













Thromboembolic (renal infarction)                                       
Multiple myeloma                                           
Intrinsic renal – see Table 4 for  clinically and histopathologicaly 












Table 4 – Pathological diagnoses of acute kidney injury including biopsy proven cases 
(Full patient data on renal biopsy findings is in Appendix 3) 
Variable                                                                                         Total (%) 
ATN predominant 
- ATN only                             
- From rhabdomyolysis   
- (Rhabdomyolysis from mob violence)     
-  With other acute (myeloma + pyelonephritis)          
272 (72.1%) 
- 260 
-   11 
-     5 
-     1 
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Acute interstitial nephritis          
- Predominant                                     
- Granulomas (excluding other granulomas)                              
Pyelonephritis  
- alone                                      
- with other                                
TMA  
- Malignant hypertension                     
- *Other TMA                                        
Multiple myeloma  (including 1 with pyelonephritis +ATN)                            
Glomerulonephritis (includes 1 clinical diagnosis) 
Pre-eclampsia                                      




- 5  
 19 (5.2%)  
- 12 







17 (4.6%)                                                
 
*(TMA – thrombotic microangiopathy) 
 
PREVENTION AND MANAGEMENT 
A total of 202 (55.2%) patients were managed in ICU, while 204 (60.7%) were dialysed 
(Table 5). Of the 204 dialysed patients, 5 did not have a clear record of the first dialysis 
modality, having had more than one dialysis modality. Of the 199 patients who did have 
data on first dialysis modality, 88 (44.2%) were on intermittent haemodialysis, while 72 
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(36.2%) were on sustained low efficiency dialysis, and 39 (19.6%) were on continuous 
veno-venous haemodialysis (Table 5). A total of 145 (39.6%) patients had both ICU 
admission and dialysis (Table 5). 
Only 195 (53.3%) patients had a documented 24 hour urine output, and 140 (38.3%) 
had a fluid input charted. A total of 100 (27.3%) patients had a documented urine 
dipstick result, and urine microscopy was done in 29 (7.9%) patients. A total of 90 







Table 5 – Patient management 
Variable                                                                    Total                                       (%) 
ICU admission                                                           202                                        55.2% 
Mechanical ventilation                                              107                                         29.2% 
Inotropes                                                                    84                                          23.0% 
Total Dialysed*                                                          204                                         55.7% 
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*(Dialysis modality – note that 5 patients had unclear data on first dialysis modality, therefore 
percentages are out of a total of 199 patients who had clear first dialysis modality)                          
First dialysis IHD*                                                       88                                            44.2% 
First dialysis SLED*                                                    72                                            36.2% 
First dialysis CVVHD*                                                 39                                             19.6%           
Dialysis and ICU                                                        145                                            39.6%         
24 hour urine output                                                  195                                             53.3% 
- [<500ml/24 hours = 113/195 (57.9%)] 
24 hour fluid input                                                      140                                              38.3%    
Urine dipstick                                                            100                                            27.3% 
Urine microscopy                                                        29                                              7.9%   
KUB ultrasound scan                                                  90                                           24.6% 
*(IHD – intermittent haemodialysis, SLED –sustained low efficiency haemodialysis, CVVHD – continuous 
veno venous haemodialysis, KUB – kidney ureter bladder) 
Timing of dialysis 
The mean time to dialysis was one day (IQR 1-2, Range 1-21) (Table 7). Among the 
119 patients returning for 3 month follow up, a total of 55 (46.2%) had dialysis. Of these, 





The overall 90 day mortality rate was 38.8% (142 patients), and the 30 day mortality 
rate was 31.2% (114 patients) (Table 6). 
An increase in the proportion of both 30 and 90 day mortality was seen with increasing 
severity stage of acute kidney injury. However, although this showed an association 
with 90 day mortality on univariate analysis (OR 1.70, p-value 0.015, 95% CI 1.11-2.61), 
multivariate analysis did not identify it as an independent predictor of mortality (Tables 6 
and 7). Both 30 and 90 day mortality rates were higher among surgical patients (36.3%) 
and 46.8% respectively) (Table 6). Univariate analysis showed a mortality association 
with surgical admissions (OR 1.65, p-value 0.026, 95% CI 1.06-2.57) but not 
multivariate analysis (Table 7). 
The 90 day mortality of patients managed in the ICU was 45.5% (92 of 202) rising to 
49.0% (71 of 145) in those who were both dialysed and managed in ICU (Table 6).  
Mortality rates increased with increasing patient age, and univariate analysis showed a 
mortality association with increasing age (OR 1.02, p-value 0.021, 95% CI 1.00-1.03). 
However on multivariate analysis, age was not an independent predictor of mortality 
(Table 7). 
There was no significant difference in the mortality rates among the different age 
categories for patients who were managed in ICU (p-value 0.484), those who were 
dialysed (p-value 0.400), or those who were both managed in ICU and dialysed (p-value 
0.484) (Table 8). 
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Both SLED and CVVHD had a mortality association on univariate analysis (OR 2.04, p-
value 0.007, 95% CI 1.21-3.44) and (OR 2.51, p-value 0.008, 95% CI 1.28-4.94) 
respectively, but they were not independent predictors of mortality on multivariate 
analysis (Table 7).  
Although HIV was found in 20.6% of the patients, it did not carry an association with 90 
day mortality on univariate analysis (OR 1.07, p-value 0.801, 95% CI 0.64-1.80) (Table 
7). 
On multivariate analysis, mechanical ventilation was the only independent predictor of 
90 day mortality (OR 2.46, p = 0.019, 95% CI 1.41-4.30), (Table 7). However, a 
borderline association with mortality was seen with sepsis (OR 1.83, p = 0.066,   95%CI 
1.02-3.27), and prolonged time to dialysis (OR 1.93, p = 0.080, CI 0.93-4.03) (Table 7). 
Among patients with hospital acquired acute kidney injury, sepsis was present in a 
greater proportion of those who were dead at 90 days compared to those who were 
alive (p-value 0.005) (Table 9). Of the 50 patients with hospital acquired acute kidney 
injury who were dead at 3 month follow up 39 (78%) had stage 3 acute kidney injury 
(Table 7). 
 
Table 6 – 30 and 90 day mortality and associated patient characteristics 
Variable  30 day mortality, N (%) 
  Medical           Surgical      Obs/Gyn                 Overall 
  N = 217            N = 124     N = 25                     N = 366   
90 day mortality, N (%)  
   Medical          Surgical       Obs/Gyn     Overall 











67 (30.9)        45 (36.3)       2 (8.0)           114/366 (31.2) 
48/120 (40.0)   28/73(38.4)   1/12 (8.3)      77/205 (37.6) 
30/72 (41.7)    28/66 (42.4)   1/7 (14.3)       59/145 (40.7) 
34/89 (38.2)   43/105 (41.0)  1/8 (12.5)       78/202 (38.6)  
                                                                     2/27 (7.4) 
                                                                     9/32 (28.1) 
                                                                  103/307 (33.6) 
                                                                        
81 (37.3)          58 (46.8)      3 (12.0)     142/366 (38.8) 
56/120 (46.7)  37/73 (50.7)  3/12 (25.0)   96/205 (46.8) 
31/72 (43.1)     37/66 (56.1)   3/7 (42.9)    71/145 (49.0) 
35/89 (39.3)    54/105 (51.4)    3/8 (37.5)    92/202 (45.5) 
                                                                      4/27 (14.8) 
                                                                      12/32 (37.5) 








Table 7 – Univariate analysis of potential risk factors for 90 day mortality and 
multivariate analysis 
Variable Univariate analysis  
OR     p-value   95%CI 
Multivariate analysis 





Surgical 58/124 (46.8%) 
Risk factors/associations 
Sepsis 102/222 (45.9%) 
Hypertension 61/152 (40.1%) 
HIV 30/75 (40.0%)  
Acute kidney injury stage 
Management  
Dialysis 96/204 (47.1%) 
ICU 92/202 (47.5%) 
Dialysis + ICU 74/145 (51.0%) 
First SLEDD 38/72 
First CVVHD 23/89 
First HD 34/88 
Mech vent 58/107 
Inotropes 43/84 
Time to dialysis 
 (Median time 1,  
IQR 1-2, Range 1-21) 
 
1.02   0.021   1.00-1.03                
1.65   0.026   1.06-2.57 
 
2.21   0.001   1.41-3.47 
1.10   0.669   0.72-1.68 
1.07   0.801   0.64-1.80 
1.70   0.015   1.11-2.61 
 
2.24   <0.001   1.45-3.47 
1.89   0.004   1.23-2.93 
2.06   0.001   1.33-3.17 
2.04   0.007   1.21-3.44 
2.51   0.008   1.28-4.94 
0.99   0.972   0.61-1.62 
2.76   <0.001   1.69-4.51 
2.27   0.001   1.37-3.76 

















2.46   0.019   1.41-4.30 
 







Table 8 – Mortality in ICU managed and dialysed patients according to age category 
 0-18              19-40           41-65            ≥ 66 




ICU + dialysis 
ICU 
2 (20.0)        46 (32.2)       67 (43.0)     27 (47.4) 
2 (20.0)        32 (22.4)       47 (30.1)     15 (26.3) 
  2 (20.0)       22 (15.4)      38 (24.4)      9 (15.4) 








Table 9 – Characteristics of patients with Hospital Acquired acute kidney injury, and 90 
day mortality, Total = 101 





Sepsis                                   38 (76.0%)                   25 (49.0%)           63/101 (62.4)                      0.005 
Dialysis                                 30 (60.0%)                   17 (33.3%)           47/101 (46.5)                      
0.00739 
AKI stage 3                           39 (78.0%)                   33 (64.7%)           72/101 (71.3)                      0.018   
AKI stage 2                           0 (20.0%)                      8 (15.7%)              8/101 (7.9)                                     
AKI stage 1                           1 (2.0%)                       10 (19.6%)           11/101 (10.9)   
Fluid balance                         26 (52.0%)                  28 (54.9%)            54/101 (53.5)                      0.613 
Urine output recorded            32 (64.0%)                  28 (54.9%)            60/101 (59.4)                     0.365 
Contrast                                  9 (18.0)                       9 (17.7%)             18/101 (17.8)                      0.963                                               
 
 
Renal recovery  
Of the 224 patients who were alive at 3 months, a follow up serum creatinine at 90 days 
or more, was available in only 119 (53.1%) of the patients. Of these, complete renal 
recovery occurred in 95 (80.5%) patients and 4 (3.4%) went onto end stage renal 
disease (Table 11). 
Of the 57 patients who were managed in ICU but not dialysed, 47 (82.5%) had full renal 
recovery. Among the 40 patients who were admitted to ICU and dialysed, and who had 
a follow up serum creatinine, 31 (77.5%) had full renal recovery (Table 10). 
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Only 18 (69.2%) of the 26 patients with HIV had full renal recovery on follow up at 3 
months (Table 10). 
Of the 4 patients who went on to end stage renal disease, 3 were aged 19-40 (Table 
11), 2 were HIV positive and 3 had been managed in the intensive care unit. 
Additionally, all 4 of them had had sepsis and dialysis (Table 10). (Long term renal 
replacement therapy was offered for  2 of the patients with end stage renal disease, 
including one who was HIV positive. One patient was lost to follow up and one 
absconded).  
Of the patients with a follow up serum creatinine at 90 days or more, all those aged 18 
or younger had full renal recovery, but only 31 (68.9%) of those aged 19-40 years had 
full renal recovery, with 31 out of 45 (68.9%).This was in contrast to full renal recovery 
in 86.5% of those aged 41-65 years, and in 84% of those aged 66 years and older 





Table 10 – Predictors of renal recovery in patients with 3 month (90 day) followed up, 
N=119 
Variable                           Yes, N =95           Partial, N =20           No, N = 4               p-value  
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Sepsis, N (%)                  48 (50.5)               12 (60.0)                   4 (100)                  0.002         
ICU, N (%)                      47 (49.5)                 7 (35.0)                   3 (75.0)                  0.018 
Dialysed, N (%)               42 (44.2)                9 (45.0)                   4 (100)                   0.001    
ICU,dialysis, N (%)          31 (32.6)                6 (30.0)                   3 (75.0)                  0.022 
HIV, N (%)                       18 (50.5)                6 (30.0)                   2 (50.0)                  0.383  
 
Table 11 – Renal recovery and age category, N= 119 
Age range                      Full recovery                      Partial recovery      No recovery                       Total                                
0-18 y                             3                                           0                            0                                           3                                
19-40                             31                                         3                           11                                         45                            
41-65                             45                                         1                            6                                          52                              
≥ 66                               16                                         0                            3                                          19                                                                                     
 Total                             95                                         4                           20                                       119                                                
 
 
Table 12 – Comparison between patients followed up at 3 months and those lost to 3 
month follow up 




                                            (dialysed = 55/119 (46.2%))     ( (dialysed = 53/103 (50.5%))                                                         
                                                     
Age, median (IQR)              44 (35-59)                               39 (30-55)                                                
0.049                            
Ethnicity, N (%)                                                                                                                                    
0.982 
Coloured                             61 (51.3%)                               51 (50.4%)                                               
Black                                   47 (39.5%)                              44 (40.7%)                           
White                                   10 (8.4%)                                 9 (8.0%)                                                       
Other                                     1 (0.84%)                                1 (0.88%) 
Sepsis, N (%)                       64 (53.8%)                              56 (53.3%)                                             0.946        
Mech vent, N (%)                 34 (28.6%)                             15 (14.3%)                                              0.017   
ICU, N (%)                           58 (48.7%)                              53 (44.5%)                                              
0.640  
Dialysis, N (%)                      55 (46.2%)                             53 (50.5%)                                             0.525            










We conducted a prospective observational study of the patient population at Groote 
Schuur Hospital, a tertiary institution in South Africa, to investigate the epidemiology, 
management and outcomes of acute kidney injury. The overall incidence of acute 
kidney injury was derived from the total number of non-private patient hospital 
admissions to the institution for the period 2011-2012. The number of admissions was 
44,285, equating to an incidence proportion of 0.83% (Appendix 4).  
This incidence proportion is low compared to recent reports from developed countries 
where the incidence is rising (Waikar, Liu et al. 2008). A possible reason may be that 
this figure is an under-estimate of the true incidence of acute kidney injury in the 
hospital and may be explained by the low referral of patients to the Renal Unit. 
Ethnicity and age    
The ethnic distribution of the patients in our study mirrored that of the Western Cape, 
which is predominantly made up of Coloured patients, closely followed by Black patients 
and fewer White patients (Statistics South Africa. Mid-year Population Estimates, 2013). 
Our finding of a mean patient age of 45.6 was slightly younger than the age noted in a 
study on medical admissions to Groote Schuur Hospital by Myer et al, which reported a 
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mean age of 49 in 2009 (Myer, Smith et al. 2013). The age range (13-91) in our study 
included both young adults and elderly patients and differed from the trends seen in 
other developing countries, where acute kidney injury is reported to affect mainly young 
patients (Cerda, Cerda et al. 2007, Cerda, Lameire et al. 2008, Cerdá, Bagga et al. 
2008, Cerdá, Bagga et al. 2008).  
We found that there were more male than female patients with acute kidney injury. This 
pattern differs from the Western Cape demographics, where there is a slight female 
predominance at 51.9% (Statistics South Africa. Mid-Year Statistical Estimates,2013). 
Based on this demographic statistic, one would expect to see more female patients 
presenting at the hospital. This expectation would also be in keeping with previous 
studies of adult patients with acute kidney injury conducted worldwide which tend to 
show a predominance of female patients (Liano, Pascual 1996, Bagshaw, Uchino et al. 
2007).  
Risk factors   
We found that patient risk factors for acute kidney injury reflected a combination of 
those found in both developed and developing countries. These consisted of non-
communicable diseases (such as hypertension, diabetes mellitus, and heart failure), 
obstetric causes and infectious diseases (HIV and tuberculosis).  
We also found that a large proportion of the patients (41.5%) we studied had 
hypertension as a risk factor. Hypertension is a potential cause of chronic kidney 
disease, which is a recognized risk factor for acute kidney injury (Lafrance, Djurdjev et 
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al. 2010). Our finding may be due to the increasing prevalence of this condition in the 
South African population (Naicker 2009).  
We also note that the proportion of patients with HIV (20.6%) was higher than the 
national prevalence of HIV in South Africa, which was placed at 10% in the 2011/2012 
census, published in May 2013 (Statistics South Africa. Mid-Year Statistical 
Estimates,2013). Our finding may be explained by the fact Groote Schuur Hospital is a 
tertiary centre that receives referrals from both secondary and primary level health 
facilities, including severely ill HIV positive patients.  
 Source of acute kidney injury 
Patients were referred from the medical discipline (59.3%), the surgical discipline 
(33.9%) and the obstetrics and gynaecology department (6.8%). The low percentage of 
obstetric and gynaecology cases may be due to national efforts to improve maternal 
and child health care (Li, Burdmann et al. 2013). 
Similarly to other developing countries, the majority of patients (72.4%), had community 
acquired acute kidney injury (Cerdá, Bagga et al. 2008). Although patients with hospital 
acquired acute kidney injury were in the minority (27.6%), the majority of these patients 
(71.3%) had stage 3 acute kidney injury and sepsis (62.4%). This high percentage may 
be explained by a delay in detection of deterioration in the clinical condition of 






We found that sepsis was the most common cause of acute kidney injury across all the 
referring disciplines (60.7%). Among patients who had community acquired acute 
kidney injury this may be a reflection of the burden of communicable diseases in South 
Africa. Among patients with hospital acquired acute kidney injury, this may reflect the 
rates of nosocomial infections in the hospital, such as Acinetobacter baumanii in the 
ICU setting (Gounden, Bamford et al. 2009) . 
The proportion of patients with obstruction (17%) is comparable to that found in studies 
conducted in Sudan, where the percentage of patients in whom obstruction was a cause 
of acute kidney injury ranged from 12.3% to 27.9% (Elsharif, Ibrahim et al. 2010, 
Kaballo, Khogali et al. 2007). While the percentage in our study is significant, it is 
important to note that a kidney ureter bladder ultrasound scan, which plays an important 
role in the initial exclusion of obstruction, was only performed on 29% of the 366 
patients included in the study. 
A histopathological cause of acute kidney injury was obtained in 36 (9.6%) patients who 
had a renal biopsy. The histopathological diagnosis was used to guide the management 
and prognostication of the patients. The diagnoses included glomerulonephritis in 19 
patients and granulomas (in combination with other findings) in 8 patients. While a key 
difference in our study was the frequent detection of mesangiocapillary 
glomerulonephritis and granulomas, these histopathological diagnoses were similar to 
those found in the studies by Liano et al in Spain, and Kaballo et al in Sudan (Kaballo, 
Khogali et al. 2007, Liano, Pascual 1996).   
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Our study therefore found that causes of acute kidney injury in our patient population 
included those common to developing countries (such as herbal toxins, 
glomerulonephritis, and gastroenteritis) , as well those common to developed countries, 
(such as post surgery and iodine based radio-contrast)  (Naicker, Aboud et al. 2008, 
Cerdá, Bagga et al. 2008). 
 
Management 
Our findings show that the overall percentage of patients who received dialysis was 
55.7%. We also found that 51% of ICU admissions presenting with acute kidney injury 
received dialysis. This finding of a high percentage of ICU managed patients treated 
with dialysis was similar to the experience of urban areas of other developing countries 
(Cerdá, Bagga et al. 2008) 
This study found that the most commonly used first dialysis modality was intermittent 
haemodialysis (44.2%). This was followed by slow low efficiency dialysis (36.2%) and 
continuous veno-venous haemodialysis (19.6%). This differs from the experience in 
other developing countries where peritoneal dialysis is the most common modality 
(Gabriel, Caramori et al. 2009).  
Although both sustained low efficiency dialysis and continuous veno-venous 
haemodialysis were associated with mortality on univariate analysis (OR 2.04) and (OR 
2.51) respectively, they were not independent predictors of mortality on multivariate 
analysis. A multicentre prospective randomized controlled trial of ICU patients with 
acute kidney injury, by Lins et al found no difference in outcome between patients 
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treated with intermittent or continuous renal replacement therapy (Lins, Elseviers et al. 
2009). However the use of continuous renal replacement therapy has been associated 
with better fluid removal than intermittent renal replacement therapy, which is important 
because fluid overload in patients with acute kidney injury carries a mortality risk 
(Bouchard, Soroko et al. 2009). Furthermore, there is evidence for better renal outcome 
in inotrope dependant patients with acute kidney injury who are treated with continuous 
renal replacement therapy, in that fewer of them go on to require chronic dialysis 
compared to those who are treated with intermittent renal replacement therapy (Prowle, 
Bellomo 2010). 
Our study illustrated that not many patients received basic bedside investigations and 
management in the form of fluid balance charts, urine dipsticks and urine microscopy, 
which are key in making the diagnosis of acute kidney injury (KDIGO 2012). This may 
be explained by staffing issues, especially in the general, non-ICU wards, which 
typically have higher patient to medical staff ratios. 
 
Prevention  
One of the aims of the study was to identify potential areas of prevention of acute 
kidney injury. In our study, the majority of patients with hospital acquired acute kidney 
injury had stage 3 disease (71.2%), suggesting that the opportunity for earlier 
intervention to prevent progression from less severe disease was missed.  
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A large proportion of these patients (62.4%) also had sepsis, which was associated with 
mortality (p-value 0.005). It may be that earlier detection and management of sepsis in 
these in-hospital patients could have prevented the development of acute kidney injury.  
Prevention and early detection are essential in reducing acute kidney injury related 
mortality. It is therefore imperative that clinicians are aware of high risk patients. This is 
especially important when one considers the high cost of renal replacement therapy in 





Our study found that 80.3% (114/142) of patients died within 30 days of acute kidney 
injury diagnosis. The overall 90 day mortality rate of 38.8% was slightly lower than that 
reported by Ali et al of 41%, in a population that included patients with the full spectrum 
of acute kidney injury, and which was similar to our study in this respect (Ali, Khan et al. 
2007).  
 
The mortality rate among ICU patients requiring dialysis was very high, at 49%. This 
figure is higher than reports from the Finnish Acute Kidney Injury (FINNAKI) study, a 
recent multicentre trial looking at patients in Finnish ICUs, which reported a 90 day 
mortality rate of 33.7% (Nisula, Kaukonen et al. 2013). This may be due to the fact that 
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in our study we had a higher proportion of patients with stage 3 acute kidney injury, who 
comprised 41% of the overall patient mortality. 
 
The strongest independent predictor of mortality on multivariate analysis in our study 
was mechanical ventilation (OR, p-value, 95% CI).  This finding was similar to the 
finding in the multinational and multicentre study of acute renal failure in critically ill 
patients conducted by Uchino, Kellum et al. This study was undertaken before the 
introduction of the consensus definition of acute kidney injury and found mechanical 
ventilation to be one of the independent risk factors for in hospital mortality (Uchino, 
Kellum et al. 2005).  
 
Another possible explanation for the finding that mechanical ventilation was an 
independent predictor of mortality in our patients is that there is evidence to suggest 
that deleterious organ cross-talk occurs between the kidneys and distant organs. This is 
due to cytokine related pathways (Feltes, Van Eyk et al. 2008). Additionally, there is 
evidence, from both animal and human studies, to suggest that primary acute lung 
injury itself may contribute to acute kidney injury (Grams, Rabb 2012). This was 
illustrated by findings from the first Acute Respiratory Distress Syndrome Network Trial 
conducted from 1996 to 1999. This study found that 24% of patients with acute 
respiratory distress syndrome developed acute kidney injury (defined as a serum 
creatinine level higher than 177µmol/l) within the first four days of enrolment in the study 




Variables carrying a borderline significant association with mortality on multivariate 
analysis in our study were sepsis (OR 1.83, p-value 0.066, 95% CI 1.02-3.27), and time 
to dialysis (OR 1.93, p-value 0.080, 95% CI 0.93-4.03. This was consistent with 
previous studies that identified both as carrying mortality associations (Bagshaw, 
Uchino et al. 2007, Mehta, T PASCUAL et al. 2004). 
 
Although our findings demonstrated an increase in 30 and 90 day mortality rates with 
increasing severity stage of acute kidney injury, it was not an independent predictor of 
90 day mortality on univariate anlaysis. This may be because a large proportion of the 
patients had stage 3 acute kidney injury, which may have been a confounder in the 
ability to detect the effect of the stage of acute kidney injury on mortality in our patients. 
However, as previously discussed, other studies have shown a clear correlation 




The 80.5% rate of full renal recovery in our patients was lower than that reported in the 
Northern Scotland study by Ali et al, which reported full renal recovery rates of 92.5% 
(Ali, Khan et al. 2007).  In addition, the percentage of patients with partial renal recovery 
(16.8%) is worrying in a country with limited access to renal replacement therapy. This 
is because such patients will require follow up and, at a later stage may require initiation 




A significant finding was that all of the patients going into end stage renal disease (no 
renal recovery) started off with an abnormal baseline serum creatinine. This finding of 
the acceleration of underlying chronic kidney disease to end stage renal disease after 
an episode of acute kidney injury is consistent with findings in other studies (Ishani, Xue 
et al. 2009, Venkatachalam, Griffin et al. 2010). 
 
Only 53.1% of the patients who were alive at 90 days were available for a follow up 
serum creatinine. This was despite continued efforts to contact patients by telephone. 
As a result, some of the follow up serum creatinine results were obtained from 
laboratory records of patients returning for follow up or for admission under different 
departments. 
 
We therefore compared the characteristics of the patients who had returned for follow 
up serum creatinine at or after 3 months to those who had not, in order to detect any 
differences between them that could affect our interpretation of the pattern of renal 
recovery in our study population. We found more mechanically ventilated patients 
among those returning (p-value 0.017). We also found that these patients were slightly 
older (p-value 0.049. Other comparisons incorporating data on demographics, 
management and sepsis found no differences between the two groups. 
A large proportion of patients that did not exhibit full renal recovery was the 19-40 age 
group. Although this age group also had the highest rates of HIV infection (61.3%), 
(thus predisposing them to chronic kidney disease in the form of HIV associated 
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nephropathy), we found no correlation between HIV and renal recovery (p-value 0.383) 
in our study. 
 
Timing of dialysis  
One of the objectives of this study was to assess the effect of timing of dialysis on 
patient outcomes. Although the study was not adequately powered to make definitive 
conclusions about these effects, we found that there was a borderline increase in 
mortality risk with delayed chronological time to dialysis (OR 1.93, p-value 0.080, 95% 
CI 0.93-4.03). 
As previously discussed, delayed chronological time to dialysis was found to be a better 
mortality indicator than BUN and serum creatinine levels in the BEST KIDNEY study, 
which discussed the potential confounders with the use of these biomarkers (Bagshaw, 
Uchino et al. 2007).  
The available evidence therefore seems to suggest that earlier dialysis has better 







This was a prospective study of real time clinical practice, which employed retrospective 
analysis. As a result, the data obtained was dependant on that recorded by the clinician, 
and required patient data may have been missed due to clinician time limitations. 
Many patients did not have a baseline serum creatinine level and, of those who did, the 
lowest reading over the last year was recorded as the baseline. Previous studies have 
used the ADQI recommendation of estimating the baseline serum creatinine level based 
on the Modification of Diet in Renal Disease (MDRD) study equation, which assumes a 
normal baseline GFR (Bellomo, Ronco et al. 2004). We elected not to use the MDRD 
equation in our study, instead deeming patients to have had acute kidney injury based 
on recovery of renal function, where a baseline serum creatinine level was missing.  
This decision was based on evidence that the accuracy of the MDRD study equation 
has limitations (Bagshaw, Uchino et al. 2009). Evidence suggests that using the MDRD 
equation in estimating the baseline serum creatinine level (for purposes of determining 
a patient’s RIFLE classification) is more useful if the baseline creatinine level is near 
normal. Furthermore, it has been concluded that the MDRD equation overestimates the 
incidence of acute kidney injury in those with chronic kidney disease (Bagshaw, Uchino 
et al. 2009).  
Due to missing patient variables, we were not able to use physiological severity illness 
scoring methods such as the APACHE score. However, acute kidney injury stage was 
used as the main marker of patient illness, as it has been shown to correlate to mortality 
outcome (Thakar, Christianson et al. 2009). We also relied on a retrospective study of 
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medical ICU patient records carried out by Barrantes et al which found that acute kidney 
injury as defined by the AKIN criteria, was a better predictor of in-hospital mortality than 
the APACHE II score (Barrantes, Tian et al. 2008). 
 
Another limitation in our study was the low proportion of patients returning for 3 month 
follow up.  Nonetheless, we found that among the patients that did not return for follow 
up, fewer were mechanically ventilated and that they were younger. This could suggest 
that they were less severely ill than those returning for follow up, and that the results 
obtained can be expected to be a reasonable reflection of renal recovery in our patient 
population. 
 
The last limitation of this study was that it was not funded. We were therefore not able to 
hire a dedicated research assistant to assist with data collection. This had an impact on 
our ability to adequately cross-check for missing data and therefore may have 









Conclusion and Recommendations 
This is the first study to look at the epidemiology, management and outcome of the full 
spectrum of acute kidney injury among patients referred to the Groote Schuur Hospital 
Renal Unit. Our study is unique among studies from the region in that we set out to 
follow up patients at 3 months in order to assess renal recovery and progression to 
chronic kidney disease. To our knowledge, other studies in the region have only 
focused on in-hospital outcomes. 
 
Our study found that acute kidney injury carries a high mortality risk and that this risk is 
highest among mechanically ventilated patients. We also found that sepsis and delayed 
time to dialysis may be associated with a high mortality risk.  
 
A significant proportion of patients with hospital acquired acute kidney injury had stage 
3 acute kidney injury and sepsis. Based on this finding, we recommend that efforts be 
made to enable early detection and treatment of deteriorating patients. Such efforts 
could involve the use of an early warning scoring system that can be incorporated into 
patient observation charts. As previously discussed in this paper, a study of the use of 
this system in hospitals in the United Kingdom found that it enabled early detection of 
patients at risk of adverse outcome and prompt intervention. 
 
A key finding in this paper was that basic bedside investigations and fluid balance chart 
records were missing in a significant number of patients. As these are essential in the 
assessment of patients with acute kidney injury, we recommend that efforts to improve 
75 
 
on this be made. This may need to involve hospital management as it relates to human 
resource capacity. 
 
We also found that a significant number of patients did not have full renal recovery; a 
factor that contributes to the burden of chronic kidney disease in the Western Cape 
region. This reinforces the importance of a management plan that requires patient follow 
up at 3 months following an episode of acute kidney injury. 
 
Lastly, we considered the impact of HIV as a risk factor when determining patient 
outcome. We found that while HIV is an important co-morbidity to consider in South 
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Renal biopsy results  
PATIENT  RENAL BIOPSY RESULT 
1 ATN, GRANULOMAS – ZIEHL NEELSEN STAIN POSITIVE GRANULOMAS  
2 HIVAN, GRANULOMAS 
3 ASCENDING PYELONEPHRITIS 
4 CRESCENTS, MESANGIOCAPILLARY GN 
5 ATN, GRANULOMAS 
6 LUPUS NEPHRITIS CLASS V, NECROTISING LESIONS, CRESCENTS 
7 ACUTE POST INFECTIOUS GN 
8 NECROTISING LESIONS, GRANULOMAS 
9 ATN, INTERSTITIAL HIVAN 
10 MESANGIOPROLIFERATIVE GN, ATN, GRANULOMAS 
11 HIVAN, ACUTE INTERSTITIAL NEPHRITIS* 
12 MESANGIOPROLIFERATIVE GN, ATN 
13 MESANGIOCAPILLARY GN, CRESCENTS 
14 MESANGIOCAPILLARY GN, CRESCENTS, LUPUS NEPHRITIS CLASS IV 
15 MESANGIOCAPILLARY GN, CRESCENTS, ?LUPUS NEPHRITIS CLASS IV, ATN 
16 MESANGIOCAPILLARY GN, ?LUPUS NEPHRITIS CLASS IV 
17 ATN 
18 NECROTISING LESIONS, IgA 
19 ACUTE POST STREPTOCOCCAL GN/POST INFECTIOUS GN 
20 ACUTE MESANGIOCAPILLARY GN, CRESCENTS, ACUTE INTERSTITIAL NEPHRITIS  
21 ACUTE POST STREPTOCOCCAL GN/POST INFECTIOUS GN 
22 EOSINOPHILS, GRANULOMAS 
23 HIVAN 
24 ATN, HIVAN 
25 GRANULOMAS, ATN, INTERSTITIAL FIBROSIS 
26 HYPERTENSION WITH CRENATION,? ATN, INTERSTITIAL FIBROSIS 
27 ATN, EXCLUDE LIGHT CHAIN DEPOSITION DISEASE 
99 
 
28 ACUTE POST STREPTOCOCCAL GN 
29 HIVAN, MALIGNANT HYPERTENSION, ASCENDING PYELONEPHRITIS 
30 MALIGNANT HYPERTENSION, ASCENDING PYELONEPHRITIS,INTERSTITIAL FIBROSIS 
31 MEMBRANOUS GN, HIVAN – FOETAL VARIANT, HYPERTENSION 
32 MALIGNANT HYPERTENSION 
33 MESANGIOCAPILLARY GN, CRESCENTS, LUPUS NEPHRITIS CLASS IV 
34 ACUTE POST INFECTIOUS GN, CRESCENTS 
35 MESANGIOCAPILLARY GN 
36 HIVAN, GRANULOMAS, ASCENDING PYELONEPHRITIS 
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